Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure

Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From... This phase 2 clinical trial investigates whether injecting the myocardium of patients with heart failure with a high dose of mesenchymal precursor cells derived from bone marrow stem cells, compared with a sham injection, repairs myocardial damage enough to facilitate weaning from left ventricular assist devices (LVADs). http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Loading next page...
 
/lp/american-medical-association/intramyocardial-injection-of-mesenchymal-precursor-cells-and-PvAqtiuCe4

References (17)

Publisher
American Medical Association
Copyright
Copyright 2019 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2019.2341
Publisher site
See Article on Publisher Site

Abstract

This phase 2 clinical trial investigates whether injecting the myocardium of patients with heart failure with a high dose of mesenchymal precursor cells derived from bone marrow stem cells, compared with a sham injection, repairs myocardial damage enough to facilitate weaning from left ventricular assist devices (LVADs).

Journal

JAMAAmerican Medical Association

Published: Mar 26, 2019

There are no references for this article.